跳至主要内容
临床试验/IRCT20240609062058N1
IRCT20240609062058N1招募中3 期

Investigating the combination of Q10 supplement with statin in reducing lipid profile and preventing the occurrence of statin complications in patients with acute coronary syndrome

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 70 years(—)
性别
All

入选标准

  • Confirmed ACS diagnosis
  • Age less than 70 years
  • Complete satisfaction (patient or patient's companion)

排除标准

  • breastfeeding
  • GFR<30 ml/min
  • acute kidney injury
  • Taking any type of supplement or lipid-lowering drug except atorvastatin with a daily dose of 80 mg
  • underlying liver disease and high liver enzymes in initial tests
  • Consumption of less than 90% of prescribed supplements
  • Lack of consent to participate in the study

研究者

相似试验